Medication info

Latrol Injection (Tramadol Hydrochloride)

Prescription medicationIntramuscular injection · Intravenous injection
Ingredient · strength
Tramadol Hydrochloride›50mg / 1mL
Manufacturer / importer
Korea Union Pharma Co., Ltd.
Appearance
Colorless and transparent ampoule containing a colorless liquid
Packaging
Domestic use - 1 milliliter/ampoule [×50 ampoules], Export use - 1 milliliter/ampoule [×10 ampoules], Export use - 2 milliliters/ampoule [×10 ampoules]
Approval status
Active

MFDS item code 200201275 · Notified 2002.04.12 · Insurance code 665500671

Summary

Main use
Relief of pain after diagnostic procedures or surgery, and moderate to severe acute and chronic pain (such as cancer pain)
Who receives it
Adults
Adult administration
The dose should be adjusted according to the severity of the patient's pain and clinical response. In general, use the lowest dose that provides pain relief. Adults Administer 50-100mg of tramadol hydrochloride per dose by intravenous or intramuscular injection, then repeat every 4-5 hours as needed. A maximum of 400mg per day may be administered. Elderly patients No dose adjustment is necessary in patients aged 75 years or younger who have no clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.

Ingredients

Manufacturer
Korea Union Pharma Co., Ltd.

Efficacy & effects

Relief of pain after diagnostic procedures or surgery, and moderate to severe acute and chronic pain (such as cancer pain)

  • Severe pain
  • moderate acute and chronic pain
  • cancer pain
  • post-diagnostic pain
  • post-surgical pain
View approved original text

This medication is used to relieve severe and moderate acute and chronic pain, particularly pain caused by various cancers and pain occurring after diagnosis or surgery.

How it is given

Adult administration

The dose should be adjusted according to the severity of the patient's pain and clinical response. In general, use the lowest dose that provides pain relief. Adults Administer 50-100mg of tramadol hydrochloride per dose by intravenous or intramuscular injection, then repeat every 4-5 hours as needed. A maximum of 400mg per day may be administered. Elderly patients No dose adjustment is necessary in patients aged 75 years or younger who have no clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.

Precautions

This medication can cause seizures if used above the recommended dosage, so it must be used with caution in patients at risk of seizures. Additionally, long-term use may lead to psychological and physical dependence, so it should be administered only for a short period under strict supervision in patients at risk of drug abuse. It can cause severe drowsiness, respiratory depression, coma, and in severe cases, death when taken with central nervous system depressants or alcohol, so extreme caution is required when used together. Patients who genetically metabolize this drug quickly may have increased blood levels of active metabolites, raising the risk of respiratory depression; therefore, dosage adjustment or alternative medications may be necessary for these patients. This medication should not be administered to children under 12 years of age or adolescents under 18 years of age who have undergone tonsillectomy or adenoidectomy, and in adolescents aged 12 to 18, it should be avoided if there are special risk factors. It should not be used in patients with acute alcohol intoxication, central nervous system drug intoxication, severe respiratory depression, head injury or brain lesions, those taking MAO inhibitors, severe liver or kidney dysfunction, pregnant women, or nursing mothers. This medication may have interactions that exacerbate side effects when taken with other analgesics or central nervous system depressants. When co-administered, dosage should be reduced, and patient conditions should be closely monitored. During treatment, drowsiness and dizziness may occur; thus, driving or operating dangerous machinery should be avoided, and tolerance may develop, leading to a gradual increase in dosage which could cause withdrawal symptoms if abruptly discontinued. In case of overdose, severe respiratory depression and seizures may occur, requiring immediate emergency treatment, and if necessary, administration of antidotes and maintenance of respiratory and cardiovascular functions. This medication should be stored out of reach of children, and kept in the original container to prevent drug misuse and deterioration of quality.

Side effects

  • Cramps
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • hives
  • bronchospasm
  • angioedema
  • respiratory depression
  • dyspnea
Show 69 more
  • asthma exacerbation
  • hiccups
  • palpitations
  • coldness
  • mimicry concerns
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heaviness
  • agitation
  • tremors
  • tinnitus
  • numbness in both hands
  • anxiety
  • exhaustion
  • fatigue
  • lethargy
  • sweating
  • dizziness
  • unsteadiness
  • discomfort
  • urinary retention
  • dry mouth
  • thirst
  • confusional state
  • cooperation impairment
  • joylessness
  • restlessness
  • sleep disturbance
  • cognitive impairment
  • hallucinations
  • amnesia
  • concentration impairment
  • depression
  • appetite changes
  • sensory disturbances
  • epileptic seizures
  • involuntary muscle contractions
  • reduced mobility
  • urinary obstruction
  • frequent urination
  • menopausal syndrome
  • urination disorders
  • menstrual disorders
  • Stevens-Johnson syndrome
  • skin reactions
  • sweating
  • allergic reactions
  • fever
  • heat sensation
  • chills
  • cold sensation
  • visual impairment
  • taste impairment
  • weight loss
  • injection site irritation
  • withdrawal symptoms
  • panic attacks
  • severe anxiety
  • sensory disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Colorless and transparent ampoule containing a colorless liquid

Package unit

Domestic use - 1 milliliter/ampoule [×50 ampoules], Export use - 1 milliliter/ampoule [×10 ampoules], Export use - 2 milliliters/ampoule [×10 ampoules]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.